Most Recent
Novartis unit Sandoz AG has filed an appeal after it was was barred from selling a generic version of top-selling blood clot drug Xarelto and failed to revoke two Bayer patents for the drug.
Accounting firm KPMG has asked the High Court for a second time to weigh in on the relevance of a contingency fee order made in a Victoria Supreme Court class action to its bid to transfer the case to NSW.
A union has partially won a bid to exclude thousands of current and former members from a class action against McDonald’s, after losing a challenge that sought to ban all Fair Work group proceedings.
Qantas has been found guilty of a safety violation for standing down a worker who raised concerns about unsafe work conditions during the early days of the coronavirus pandemic.
A judge overseeing a class action against Optus has said there is scope for the teleco to seek redactions of portions of a Deloitte report, which he ruled last Friday failed the test for protection under legal professional privilege.
Optus has lost its fight to keep a class action from accessing an independent report by consulting giant Deloitte into last year's major data breach.
South Australian MP Rebekha Sharkie has asked a court to throw out a "misconceived" lawsuit by a former staffer accusing her of bullying, saying she is not an 'employer' under the Fair Work Act.
EnergyAustralia has hit back at a lawsuit by Australian parents accusing it of misleading customers, saying it was "valid" to market its products involving a carbon offset scheme as 'carbon neutral'.
Novartis unit Sandoz AG has lost its bid to revoke Bayer’s patents for its top-selling blood clot drug Xarelto and has been barred from selling generic versions of the medication after a judge found the German pharma giant’s patents were valid.
An advocacy group has appealed a judgment that found it was "legally open" to federal environment minister Tanya Plibersek to approve the extension of two mega coal mines in New South Wales.